Source: Annual Congress 2007 - Diagnostic tests and treatment in non cystic fibrosis bronchiectasis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. A. Anwar, S. Bourke, G. Afolabi, P. Middleton, C. Ward, R. Rutherford (North Shields, Newcastle upon Tyne, United Kingdom). Outcome of dedicated immune profiling in adult non-cystic fibrosis bronchiectasis. Eur Respir J 2007; 30: Suppl. 51, 3182

Member's Comments

No comment yet.

Related content which might interest you: The pulmonary microbiome in non-cystic fibrosis bronchiectasis. Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Diagnostic imaging in adult ?non-cystic fibrosis bronchiectasis Source: Breathe, 15 (3) 190; 10.1183/20734735.0009-2019 Year: 2019 Etiology and clinical outcome of pediatric non-cystic fibrosis bronchiectasis Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities Year: 2010 The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2019; 83: 158-172 Year: 2019 Phenotype characterization of non-cystic fibrosis bronchiectasis in India. Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Clinical and functional profile of patients with non-cystic fibrosis bronchiectasis according to the presence of chronic bronchial infection Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Outcomes and survival following lung transplantation in non-cystic fibrosis bronchiectasis Source: ERJ Open Res, 8 (1) 00607-2021; 10.1183/23120541.00607-2021 Year: 2022 Physical activity evaluation in non-cystic fibrosis bronchiectasis patients Source: International Congress 2017 – Assessing pulmonary and extra-pulmonary function in chronic disease Year: 2017 Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases Year: 2018 Global burden of non-cystic fibrosis bronchiectasis: A simple epidemiological analysis Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012 New proteomic biomarkers of cystic fibrosis: a comparison with non-CF bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 240s Year: 2005 Lung function in non-cystic fibrosis bronchiectasis – determinant factors Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Management and prevention of non-cystic fibrosis bronchiectasis Source: International Congress 2015 – PG9 Lower respiratory tract infection in children Year: 2015 Global impact of bronchiectasis and cystic fibrosis Source: Breathe 2016; 12: 222-235 Year: 2016 Changing characteristics of childhood non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection Year: 2011 Immuno-allertypes in non-cystic fibrosis  bronchiectasis Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2017; 77: 38-57 Year: 2017 Non-cystic fibrosis bronchiectasis Source: International Congress 2019 – Recent clinical advances in inhalation therapy Year: 2019 Non-cystic fibrosis bronchiectasis Source: Virtual Congress 2020 – Paediatric year in review Year: 2020 Non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2017; 77: 181-198 Year: 2017